MCMichael W. Christopher

Michael W. Christopher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael W. Christopher has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The “dark magic mushroom” co-produces amatoxins and psilocybin

    by Andrew R. Kunik, Michael W. Christopher, Benjamin Lemmond, Bryn T.M. Dentinger, Jason C. Slot, Timothy J. Garrett, Matthew E. Smith


  • Open Access

    The “dark magic mushroom” co-produces amatoxins and psilocybin

    by Andrew R. Kunik, Michael W. Christopher, Benjamin Lemmond, Bryn T.M. Dentinger, Jason Slot, Timothy J. Garrett, Matthew E. Smith

    The most famous chemicals produced by mushrooms are the psychedelic compound psilocybin from “magic mushrooms” and amatoxins from deadly poisonous mushrooms. These compounds are known to occur in multiple phylogenetically disjunct fungal lineages but have never been shown to co-occur within a single species. Here we show that the “dark magic mushroom” Galerina indica produces both psilocybin and amatoxins. Mass spectrometry revealed psilocybin and amatoxins in mushroom tissues, and genomic analyses identified corresponding biosynthetic genes. Phylogenetic analyses suggest that G. indica acquired psilocybin biosynthesis via horizontal gene transfer after amatoxin biosynthesis was already established, and that psilocybin biosynthesis was acquired twice independently within Galerina . Intriguingly, acquisition of psilocybin biosynthesis in G. indica may have coincided with reduced amatoxin potency. These findings reveal how horizontal gene transfer can combine powerful bioactive systems in a single species, potentially altering the ecological roles of both compound classes and the evolutionary fitness of the species.

  • Hydrogen–Deuterium Back-Exchange for High-Resolution Mass-Spectrometry-Based Metabolite Characterization

    by Michael W. Christopher, Aiden C. Ericson, Yingchan Guo, Gavin C. Beauchamp, Boone M. Prentice, Timothy J. Garrett

    Methods for unknown metabolite characterization rely heavily on one or more of the following: spectroscopic approaches; tandem mass spectrometry (MS/MS); ion mobility or liquid chromatography; and/or guided intervention through reverse metabolomics, derivatization, etc. The limitations of these methodologies vary widely. For example, spectroscopic approaches are slow and limited in throughput as they necessitate metabolite purification. Additionally, tandem mass spectrometry is often insufficient for unambiguous identification, and guided interventions can be limited in scope. A complementary approach to high-resolution mass spectrometry that is high-throughput, is robust, and provides nondiscrete data (i.e., unique reaction rate) that can rationally inform metabolite structure is desirable. Here, we present an optimized method utilizing sodium bicarbonate for hydrogen-deuterium exchange (HDX) to label slowly exchanging and labile sites over time, after which back-exchange of all labile sites leaves only slowly exchanging sites labeled for subsequent MS analysis. The exchange kinetics and extent of deuterium incorporation aid in metabolite structure identification. The myriads of different metabolite structures impart differences in resonance, inductive, and stearic effects at the labeling site and are resolvable kinetically. This methodology is used to identify different functional groups and provide kinetic resolution of structural isomers (methyl xanthine and methyl 2-oxovalerate as well as ortho, para, and meta isomers of hydroxyhippurate), complemented with density functional theory (DFT) calculations.


  • Open Access

    Metabolomic Changes Underpinning Permethrin Resistance in the Anopheles gambiae Vector from Cameroon

    by Steve V. Djova, Michael W. Christopher, Sulaiman S. Ibrahim, Mersimine Kouamo, Rhoel R. Dinglasan, Timothy J. Garrett, Charles S. Wondji


  • Distinguishing 4- vs 5-Hydroxy- N , N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen–Deuterium Back-Exchange

    by Michael W. Christopher, Boone M. Prentice, Timothy J. Garrett

    Distinguishing metabolite isomers often relies on comparing relative data, such as relative chromatographic retention times and ion mobility arrival time orders, or relative product ion abundances. These approaches necessitate the need for quality reference data and/or chemical standards. An ideal method for differentiating isomers would leverage one of the absolute physiochemical properties of the isomers, and would have no reliance on instrument vendor, chromatographic column chemistry, or external reference data. For example, the pKa of an aromatic hydroxy hydrogen changes according to ring position across isomers (e.g., 4- vs 5-hydroxyindole). Herein, we leverage the difference in pKa to resolve 4- and 5-hydroxy positional isomers of hydroxy-N,N-dimethyltryptamine (psilocin and bufotenine), the structural moiety of compounds with profound effects on the serotonergic system. We first use hydrogen-deuterium exchange (HDX) to rapidly exchange the indole amine hydrogen and gradually exchange the indole hydroxy hydrogen atoms to deuterium atoms. We then back-exchange the indole amine deuterium atom back to a hydrogen atom on the LC column and monitor the kinetic exchange rates of the retained aromatic hydroxy deuterium atom using high resolution mass spectrometry (HRMS). HDX kinetics allow for facile differentiation of the two isomers, with only 4-hydroxy-N,N-dimethyltryptamine exchanging at an appreciable amount within hours. These results could ultimately be used to characterize a variety of unknown structural isomers.


  • Open Access

    Analysis of Metabolomic Reprogramming Induced by Infection with Kaposi’s Sarcoma-Associated Herpesvirus Using Untargeted Metabolomic Profiling

    by Abdulkarim Alfaez, Michael W. Christopher, Timothy J. Garrett, Bernadett Papp

    Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic double-stranded DNA virus. There are no vaccines or antiviral therapies for KSHV. Identifying the cellular metabolic pathways that KSHV manipulates can broaden the knowledge of how these pathways contribute to sustaining lytic infection, which can be targeted in future therapies to prevent viral spread. In this study, we performed an untargeted metabolomic analysis of KSHV infected telomerase-immortalized gingival keratinocytes (TIGK) cells at 4 h post-infection compared to mock-infected cells. We found that the metabolomic landscape of KSHV-infected TIGK differed from that of the mock. Specifically, a total of 804 differential metabolic features were detected in the two groups, with 741 metabolites that were significantly upregulated, and 63 that were significantly downregulated in KSHV-infected TIGK cells. The differential metabolites included ornithine, arginine, putrescine, dimethylarginine, orotate, glutamate, and glutamine, and were associated with pathways, such as the urea cycle, polyamine synthesis, dimethylarginine synthesis, and de novo pyrimidine synthesis. Overall, our untargeted metabolomics analysis revealed that KSHV infection results in marked rapid alterations in the metabolic profile of the oral epithelial cells. We envision that a subset of these rapid metabolic changes might result in altered cellular functions that can promote viral lytic replication and transmission in the oral cavity.


  • Divergent Metabolic Fates of Aromatic Amino Acid-Derived Isomers: Insights from Ex Vivo Metabolomics and HDX-HRMS/MS-Based Resolution of Tautomers

    by Michael W. Christopher, Aiden C. Ericson, Alexander C. Klug, Rhoel R. Dinglasan, Boone M. Prentice, Timothy J. Garrett

    Tautomers are one of the many types of isomers, and differences in tautomeric structures confer altered chemical and biological properties. Using ultrahigh-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) ex vivo metabolomics, we investigate, in whole blood, the divergent metabolism of enol and keto forms of indole-3-pyruvate (IPyA), a tautomeric product of aromatic amino acid metabolism. Two new compounds resulting from IPyA metabolism were discovered, 3-(1H-indol-3-yl)-2,3-dioxopropanoic acid or "indole-3-oxopyruvic acid" and glutathionyl-indole pyruvate (GSHIPyA), which were characterized via ultraviolet photodissociation (UVPD) and higher-energy collisional dissociation (HCD). Computational calculations support the hypothesis that GSHIPyA forms specifically through the enol form of IPyA. GSHIPyA is also hypothesized to be tautomeric, and a hydrogen-deuterium exchange-high-resolution tandem mass spectrometry (HDX-HRMS/MS) approach is developed to prove the presence of an enol and keto tautomer. HDX of GSHIPyA labels the keto form with an additional deuterium, relative to the enol form. HRMS/MS of the labeled isomers is employed to leverage the relationship of resolving power scaling inversely with the square root of m/z, for Orbitrap mass analyzers. HRMS/MS yields a smaller-molecular-weight deuterated tautomeric product ion, reducing the analyte ion m/z and thus lowering the resolving power necessary to separate the deuterated keto tautomer product ion from the [13]C product ion.


  • Indole-3-pyruvate: Analysis and Control of Tautomerism and Reactivity

    by Michael W. Christopher, Alexander C. Klug, Jae Hwan Lee, Aiden C. Ericson, Sina Feizbakhsh Bazargani, Rhoel R. Dinglasan, Boone M. Prentice, Timothy J. Garrett

    It is well-known in biochemistry that structure confers function, meaning that chemical structural elucidation is critical to truly understanding the function of a given metabolite. Indole-3-pyruvate (IPyA) exists in an equilibrium between the keto and enol tautomeric forms. IPyA is suggested to play a role in immune function; however, determining whether the tautomeric forms function differently can only be studied if an analytical method is capable of distinguishing between the two forms. Herein, we describe the use of UHPLC-HRMS to gain insight into the physical variables that govern IPyA tautomer equilibrium, reactivity, and detection limit. We use hydrogen-deuterium exchange (HDX) to identify enol and keto peaks, and we show that tautomers exhibit a valley of fronting followed by a tailing peak shape (though separation is still attainable) and identical MS/MS spectra. We observed drastically different ratios of keto and enol forms in different solvents, which is an important consideration for in vitro studies. IPyA was found to be highly unstable with accelerated reactivity in peroxides. Through in vitro reactivity studies, IPyA produced a myriad of known and unknown metabolites via nonenzymatic processes, many of which were mapped in vivo via the analysis of human plasma. Finally, we show that vitamin C (ascorbic acid) can slow this reactivity and enable sensitive detection in whole blood.